Compositions containing alpha2-adrenergic agonist components

Details for Australian Patent Application No. 2005220199 (hide)

Owner Allergan, Inc.

Inventors Kerslake, Edward D. S.; Olejnik, Orest

Agent Davies Collison Cave

Pub. Number AU-B-2005220199

Parent 2001273269

Filing date 5 October 2005

Wipo publication date 27 October 2005

Acceptance publication date 8 March 2007

International Classifications

A61K 47/38 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Cellulose

A61K 9/08 (2006.01) Medicinal preparations characterised by special physical form - Solutions

A61K 31/557 (2006.01) - Eicosanoids, e.g. leukotrienes

Event Publications

20 October 2005 Complete Application Filed

27 October 2005 Application Open to Public Inspection

  Published as AU-B-2005220199

8 March 2007 Application Accepted

  Published as AU-B-2005220199

5 July 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005220200-Showcase

2005220198-Anti-pinching device for use in a folding chair